Ovid Therapeutics Inc. Available-for-sale Securities, Gross Realized Gain (Loss)
Ovid Therapeutics Inc. (OVID) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2021-11-10
- Ovid Therapeutics Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2021-09-30 was $0.00.
- Ovid Therapeutics Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2021-06-30 was $0.00.
- Ovid Therapeutics Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2021-03-31 was $0.00.
- Ovid Therapeutics Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2020-12-31 was $0.00.
- Ovid Therapeutics Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2020 was $0.00.
- Ovid Therapeutics Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2019 was $0.00.
- Ovid Therapeutics Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2018 was $0.00.
- Ovid Therapeutics Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2017 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2021-08-16 | $0.00 derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2021-05-13 | $0.00 derived: sum of 3 quarters · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 derived: sum of 3 quarters · filed 2021-11-10 | $0.00 10-K · filed 2021-03-15 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-15 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $0.00 10-K · filed 2020-03-11 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |